Parasitic diseases
Follow the links below to find trusted information about parasitic diseases.
Last reviewed: July 2016
Need more information?
These trusted information partners have more on this topic.
Found 171 results
Tinea - Farmer Health | Farmer Health
Tips for Tinea Tinea is a contagious fungal skin infection. Commonly affected areas include the feet (athletes foot), groin (jock itch), scalp and beneath the breasts. Tinea can be spread by skin-to-skin contact or indirectly. It is also known as...
Read more on The National Centre for Farmer Health website
Parasites - NT.GOV.AU
Scabies, strongyloidiasis, naegleria fowleri, malaria, head lice, parasites in the Northern Territory.
Read more on NT Health website
Rat Lung Worm (Angiostrongylus catonensis)
Rat lung worm is not a notifiable disease. It is an extremely rare cause of meningitis in Australia and is associated with eating infected snails and slugs. Most people make a full recovery.
Read more on NSW Health website
Infections and Parasites
Read more on Queensland Health website
Pinworms | Better Health Channel
Read more on Better Health Channel website
Malaria - Lab Tests Online AU
Malaria is an infectious disease caused by Plasmodium parasites. The parasites are spread by the bite of infected female Anopheles mosquitos. There are five types of Plasmodium (P) species which infect humans; P. malariae,P. falciparum,P. vivax,P. ovaleand P. knowlesi.
Read more on Lab Tests Online website
Cryptosporidiosis
Cryptosporidiosis is a disease caused by swallowing the Cryptosporidium parasite. It mainly causes diarrhoea and stomach cramps.
Read more on NSW Health website
Primary Amoebic Meningoencephalitis (PAM)
Primary Amoebic Meningoencephalitis (PAM) Category: Infections and Parasites Topic: Parasites Send by email View as PDF Send by post Primary amoebic meningoencephalitis (PAM) is a rare and severe disease caused by a single-celled amoeba called Naegleria fowleri
Read more on Queensland Health website
Scabies - ACD
Scabies is a condition that occurs as a result of infestation with a tiny mite (parasite) called Sarcoptes scabei var hominis.
Read more on Australasian College of Dermatologists website
Malaria overview - myDr.com.au
Malaria is a serious mosquito-borne disease that is caused by a parasitic infection of the red blood cells.
Read more on myDr website
Found 101 results
How well do point-of-care tests detect Schistosoma infections in people living inendemic areas? | Cochrane
Schistosomiasis, also known as bilharzia, is a parasitic disease common in the tropical and subtropics. Point-of-care tests and urine reagent strip tests are quicker and easier to use than microscopy. We estimate how well these point-of-care tests are able to detect schistosomiasis infections compared with microscopy.
Read more on Cochrane (Australasian Centre) website
Artemether-lumefantrine (four-dose regimen) for treating uncomplicated malaria | Cochrane
Malaria is a parasitic disease spread by mosquitoes. It affects millions of people worldwide and causes significant illness and mortality. Uncomplicated malaria presents with symptoms such as fever, headache, muscle pain, and vomiting. The parasite has become resistant to a number of previously effective drugs, and so combinations of drugs are used to try to prevent further resistance. Artemether-lumefantrine is one such drug combination. This review of trials showed that, although the four-dose artemether-lumefantrine regimen was superior to chloroquine, in general the four-dose regimen was less effective compared with the six-dose regimen or other drug combinations. The fact that the four-dose regimen is generally less effective means it is unlikely that it would be used for treating uncomplicated malaria.
Read more on Cochrane (Australasian Centre) website
Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria | Cochrane
Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria
Read more on Cochrane (Australasian Centre) website
Drugs against parasites for prevention of Chagas heart disease | Cochrane
Chagas disease is a form of heart disease that develops after decades of infection with a parasite called Trypanosoma cruzi. In addition to avoiding transmission of the parasites (through contact with insects in rural areas of many central and south American countries, blood transfusion, organ transplants from infected individuals or vertical transmission to newborns), one of the actions for prevention of Chagas disease is treating the estimated seven to 12 million infected individuals with medications against the parasites (trypanocidal therapy, or TT for short).
Read more on Cochrane (Australasian Centre) website
Deworming drugs for treating soil-transmitted intestinal worms in children: effects on nutrition and school performance | Cochrane
Read more on Cochrane (Australasian Centre) website
Corticosteroids for the treatment of parasitic eosinophilic meningitis | Cochrane
Eosinophilic meningitis is an inflammation of the membrane covering the brain, the causes of which can be broadly categorised into infectious and non-infectious. Among the infectious aetiologies, Angiostrongylus cantonensis, a rat lung worm, is the major cause of eosinophilic meningitis. It occurs principally in South-East Asia and throughout the Pacific basin. However, this parasite has spread beyond the Pacific basin and is now found in regions of North America due to infected ship rats. Severe headache, which is self limiting, is the main complaint. The headache is probably due to an immune response to the dead parasites. Other signs and symptoms include neck stiffness and pain, visual disturbances, nausea, vomiting, paraesthesia and hyperaesthesia. Corticosteroids are drugs that reduce inflammation, which can occur in eosinophilic meningitis due to dead larvae.
Read more on Cochrane (Australasian Centre) website
Helminth therapy (worms) for induction of remission in inflammatory bowel disease | Cochrane
Inflammatory bowel disease (IBD) is comprised of two disorders: ulcerative colitis and Crohns disease. These disorders have both distinct and overlapping symptoms, but the underlying cause remains incompletely understood. Standard therapy for IBD includes sulfasalazine, 5-ASA drugs, steroids, immunosuppressives such as azathioprine, 6-mercaptopurine and methotrexate and biological agents such as infliximab. Helminths are worm-like parasites, that inhabit larger organisms. Helminths cause changes in the immune systems of their hosts including an altered immunological response to antigens and this has implications for the treatment of inflammatory bowel disease which is thought to be caused by immune dysregulation.
Read more on Cochrane (Australasian Centre) website
Vaccines for preventing malaria in the blood phase | Cochrane
Malaria is a parasitic disease spread by mosquitoes. It affects millions of people worldwide and causes significant illness and mortality. Uncomplicated malaria presents with symptoms such as fever, headache, muscle pain, and vomiting, and children commonly present with rapid breathing, cough, and convulsions. Severe malaria causes unconsciousness and death. Vaccines are widely considered a necessary component for the complete success of malaria control. The parasite moves through several life-cycle stages in the human body, during which its molecular makeup changes, at least partially. Vaccines specific for each stage (ie targeting different antigens) are under development. This review looked at vaccinations targeted at the asexual (blood) phase of the parasite's life, when the parasites are in red blood cells. One vaccine for this phase, MSP/RESA (also known as Combination B), has been tested in field trials in Papua New Guinea. It reduced the density of parasites in the blood, but it did not prevent malaria attacks. Blood-stage vaccines are being actively pursued in further research.
Read more on Cochrane (Australasian Centre) website
Administration of antimalarial drugs to whole populations | Cochrane
Malaria is the most important mosquito-borne disease caused by a parasite, accounting for an estimated 660,000 deaths annually. Fortunately, malaria is both preventable and treatable. Several malaria control tools currently exist, and new and innovative approaches are continually under development.
Read more on Cochrane (Australasian Centre) website
Interventions for American cutaneous and mucocutaneous leishmaniasis. | Cochrane
American cutaneous and mucocutaneous leishmaniasis, a disfiguring and stigmatising disease affecting Central and South American regions, is caused by a parasite transmitted by sandflies. Pentavalent antimonial drugs (sodium stibogluconate (Pentostam, Stibanate, SSG) and meglumine antimoniate (Glucantime, MA)) have been used since the 1940s as first-line therapeutic agents for cutaneous leishmaniasis worldwide. However, other treatments have been used because these are expensive, toxic and painful, and because resistance is emerging.
Read more on Cochrane (Australasian Centre) website
